MGC Pharmaceuticals is expected to benefit from the United Nations’ (UN) decision to remove cannabis and its derivatives from schedule IV following recommendations from the World Health Organisation (WHO). Cannabis and its derivatives will now be contained under...

The global Cannabis Pharmaceuticals Market size is projected to reach USD 5.8 billion by 2027, expanding at a CAGR of 76.8% over the forecast period, according to a new report by Grand View Research, Inc. Rise in the number of clinical trials for these drugs due to...

Researchers in Canada have conducted a study suggesting that novel Cannabis sativa extracts may decrease levels of the host cell receptor that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses to gain viral entry to target tissues. SARS-CoV-2 is the...

Since 2019, Medicinal Cannabis Clinics (MCC) has facilitated over 4,000 medical consultations with pre-screened eligible patients and has shown continued month-on-month growth. MGC Pharmaceuticals has acquired Australian telehealth medicinal cannabis clinic Medicinal...

Available evidence indicates cannabis can improve neurological symptoms associated with Huntington disease (HD), according to the findings of a literature review published in the Journal of Pharmacy & Pharmaceutical Sciences. Researchers urge physicians to...

On Veterans Day, many of America’s former soldiers find themselves without access to plant medicine that can treat many common illnesses, including PTSD. Congress has been silent despite cannabis legalization sweeping the nation. The percentage of military veterans...